Earnings Feed
Start Free
Processa Pharmaceuticals, Inc.·4

Jan 4, 5:36 PM ET

THOMPSON VIRGIL 4

4 · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2022-12-31
Processa Pharmaceuticals, Inc.PCSA
THOMPSON VIRGIL
Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2022-12-31+18,208→ 100,213 total(indirect: By Trust)
  • Award

    Restricted Stock

    [F2]
    2023-01-01+30,000→ 30,000 total
    Exercise: $0.00→ Common Stock (30,000 underlying)
Holdings

  • Common Stock

    16,693
Footnotes (2)
  • [F1]Vesting of time-based restricted shares.
  • [F2]The Restricted Stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.
Signature
/s/ Virgil Thompson by Michael B. Kirwan, as Attorney-in-Fact|2023-01-04

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4